المؤلفون: Arnon Kater, Julie Dubois, Christian Brieghel, Sabina Kersting, Lisbeth Enggaard, Gerrit Veldhuis, Rogier Mous, Clemens Mellink, Johan Dobber, Christian Poulsen, Caspar Da Cunha-Bang, Hendrik Fredriksen, Ann Janssens, Ida Schjodt, Ellen Dompeling, Juha Ranti, Mattias Mattsson, Mar Bellido, Hoa Tran, Kazem Nasserinejad, Mark-David Levin, Carsten Niemann

المصدر: HemaSphere, Vol 7, p e10648ed (2023)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000967504.10648.ed; https://doaj.org/toc/2572-9241

URL الوصول: https://doaj.org/article/37b50e3544da4e5e91dc8c9be88c63dc

المؤلفون: Aleksandra Urban, Johanne Hermansen, Yanping Yin, Weikaixin Kong, Rebecca Teglgaard, Christian Brieghel, Sabina Kersting, Geir E. Tjønnfjord, Mark-David Levin, Hoa T. T. Tran, Mattias Mattsson, Juha Ranti, Gerrit-Jan Veldhuis, Caspar Da Cunha-Bang, Rogier Mous, Julie Dubois, Arnon Kater, Carsten Niemann, Tero Aittokallio, Sigrid Skånland

المصدر: HemaSphere, Vol 7, p e92046ec (2023)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: http://journals.lww.com/10.1097/01.HS9.0000967488.92046.ec; https://doaj.org/toc/2572-9241

URL الوصول: https://doaj.org/article/69ae2e40c7fe4a2ca9baae0e3b9e3035

المؤلفون: Juha Ranti, Katariina Perkonoja, Tommi Kauko, Heidi Loponen, Emmi I. Joensuu, Tiina M. Järvinen

المصدر: eJHaem, Vol 3, Iss 1, Pp 291-300 (2022)

مصطلحات موضوعية: chemoimmunotherapy, chronic lymphocytic leukemia, IGHV, survival, targeted therapy, Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2688-6146

URL الوصول: https://doaj.org/article/38a69ec56cf740aba60959a897469a9a

المؤلفون: Carsten Utoft Niemann, Arnon Kater, Mattias Mattsson, Sabina Kersting, Juha Ranti, Hoa Thi Tuyet Tran, Kazem Nasserinejad

المصدر: BMJ Open, Vol 10, Iss 10 (2020)

مصطلحات موضوعية: Medicine

وصف الملف: electronic resource

Relation: https://bmjopen.bmj.com/content/10/10/e039168.full; https://doaj.org/toc/2044-6055

URL الوصول: https://doaj.org/article/1aff2fd12c2a474599c41d3f15354aa5

المؤلفون: Juha Ranti, Samu Kurki, Urpu Salmenniemi, Mervi Putkonen, Soile Salomäki, Maija Itälä-Remes

المصدر: PLoS ONE, Vol 13, Iss 9, p e0204136 (2018)

مصطلحات موضوعية: Medicine, Science

وصف الملف: electronic resource

Relation: http://europepmc.org/articles/PMC6147489?pdf=render; https://doaj.org/toc/1932-6203

URL الوصول: https://doaj.org/article/ed46a18a12d04d1ab61d9757d353fa51

المؤلفون: Juha Ranti, Katariina Perkonoja, Tommi Kauko, Riku Korhonen

المصدر: Transplant infectious disease : an official journal of the Transplantation SocietyREFERENCES. 24(6)

مصطلحات موضوعية: Transplantation, Infectious Diseases

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0154492df6a8320039201d0f0b05376
https://pubmed.ncbi.nlm.nih.gov/36082437

المؤلفون: Arnon P Kater, Mark-David Levin, Julie Dubois, Sabina Kersting, Lisbeth Enggaard, Gerrit J Veldhuis, Rogier Mous, Clemens H M Mellink, Anne-Marie F van der Kevie-Kersemaekers, Johan A Dobber, Christian B Poulsen, Henrik Frederiksen, Ann Janssens, Ida Schjødt, Ellen C Dompeling, Juha Ranti, Christian Brieghel, Mattias Mattsson, Mar Bellido, Hoa T T Tran, Kazem Nasserinejad, Carsten U Niemann

المساهمون: Hematology, Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Human Genetics, ARD - Amsterdam Reproduction and Development

المصدر: The Lancet Oncology, 23(6), 818-828. Lancet Publishing Group
Kater, A P, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, van der Kevie-Kersemaekers, A-M F, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Brieghel, C, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Niemann, C U 2022, ' Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION) : primary analysis of an open-label, randomised, phase 2 trial ', The Lancet Oncology, vol. 23, no. 6, pp. 818-828 . https://doi.org/10.1016/S1470-2045(22)00220-0
Lancet Oncology, 23(6), 818-828. ELSEVIER SCIENCE INC
The Lancet. Oncology, 23(6), 818-828. Lancet Publishing Group

مصطلحات موضوعية: Sulfonamides, BCL2, Neoplasm, Residual, Adenine, PROLIFERATION, MULTICENTER, Bridged Bicyclo Compounds, Heterocyclic, BCR, Leukemia, Lymphocytic, Chronic, B-Cell, 1ST-LINE TREATMENT, Pyrimidines, Piperidines, Oncology, Antineoplastic Combined Chemotherapy Protocols, CYCLOPHOSPHAMIDE, CELLS, Humans, Pyrazoles, RITUXIMAB, FLUDARABINE, CLL

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9718c77415d917a2bcc69c56884dfe80
https://research.vumc.nl/en/publications/49812a92-aba6-438b-9c67-b32e46e2a31b

المؤلفون: Mark-David Levin, Julie Dubois, Rogier Mous, Ellen C Dompeling, Hoa T. T. Tran, Mar Bellido, Christian Bjørn Poulsen, Juha Ranti, Sabina Kersting, Ida Schjødt, Arnon P. Kater, Ann Janssens, Henrik Frederiksen, Clemens Mellink, Johan A. Dobber, Mattias Mattsson, Carsten Utoft Niemann, Lisbeth Enggaard, Gerrit J Veldhuis, Kazem Nasserinejad

المساهمون: Hematology, Human Genetics, AII - Cancer immunology, Experimental Immunology, Clinical Haematology, CCA - Cancer Treatment and Quality of Life

المصدر: Blood, 137(8), 1117-1120. AMER SOC HEMATOLOGY
Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608
Blood, 137(8), 1117-1120. American Society of Hematology
Niemann, C U, Levin, M-D, Dubois, J, Kersting, S, Enggaard, L, Veldhuis, G J, Mous, R, Mellink, C H M, Dobber, J A, Poulsen, C B, Frederiksen, H, Janssens, A, Schjødt, I, Dompeling, E C, Ranti, J, Mattsson, M, Bellido, M, Tran, H T T, Nasserinejad, K & Kater, A P 2021, ' Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia ', Blood, vol. 137, no. 8, pp. 1117-1120 . https://doi.org/10.1182/blood.2020008608

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Science & Technology, Venetoclax, business.industry, Chronic lymphocytic leukemia, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, 1ST-LINE TREATMENT, chemistry.chemical_compound, chemistry, Ibrutinib, Internal medicine, Relapsed refractory, medicine, RITUXIMAB, business, Life Sciences & Biomedicine

وصف الملف: application/pdf; Print

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdc9ad8a3176dac8f8c391574fbbaa55
https://hdl.handle.net/11370/98d01a12-fd30-4fee-916b-cdd713c9d5b3

المؤلفون: Emmi I. Joensuu, Tommi Kauko, Heidi Loponen, Juha Ranti, Tiina M. Järvinen, Katariina Perkonoja

المصدر: EJHaem. 3(1)

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Internal medicine, Chronic lymphocytic leukemia, medicine, Center (algebra and category theory), business, medicine.disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::843ba933afb8354c299194b80d2609a1
https://pubmed.ncbi.nlm.nih.gov/35846189

المؤلفون: Carsten Utoft Niemann, Kazem Nasserinejad, Sabina Kersting, Juha Ranti, Hoa Thi Tuyet Tran, Mark-David Levin, Mattias Mattsson, Arnon P. Kater

المساهمون: Clinical Haematology, CCA - Cancer Treatment and Quality of Life, Hematology

المصدر: BMJ Open, Vol 10, Iss 10 (2020)
BMJ open, 10(10):039168. BMJ Publishing Group
BMJ Open, 10(10):e039168. BMJ Publishing Group
BMJ Open

مصطلحات موضوعية: medicine.medical_specialty, lymphoma, Receptor Tyrosine Kinase-like Orphan Receptors, Helsinki declaration, chemistry.chemical_compound, Piperidines, Refractory, Recurrence, Informed consent, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Humans, Medicine, Prospective Studies, Hematologi, Sulfonamides, clinical trials, business.industry, Venetoclax, Adenine, toxicity, Hematology, General Medicine, Bridged Bicyclo Compounds, Heterocyclic, Leukemia, Lymphocytic, Chronic, B-Cell, Minimal residual disease, Clinical trial, chemistry, Creatinine, Ibrutinib, leukaemia, Tumor Suppressor Protein p53, business, Haematology (Incl Blood Transfusion)

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21148adc02aaa162f9313846dda1d40d
https://hdl.handle.net/1765/131627